Press Release: ImmunoPrecise Antibodies (IPA) Reports Financial Results and Recent Business Highlights for Second Quarter Fiscal Year 2025

Dow Jones12-10
   Sale of QVQ Holdings BV shares                 --      121 
--------------------------------------------  ------   ------ 
Net cash used in investing activities           (328)    (509) 
--------------------------------------------  ------   ------ 
Financing activities: 
   Proceeds on share issuance, net of 
   transaction costs                           1,507       -- 
   Repayment of leases                          (801)    (715) 
   Proceeds on debenture issuance, net 
   of transaction costs                        4,059       -- 
----------------------------------------      ------   ------ 
Net cash provided by (used in) financing 
 activities                                    4,765     (715) 
--------------------------------------------  ------   ------ 
Increase (decrease) in cash during the 
 period                                          370   (1,794) 
Foreign exchange                                (294)    (468) 
Cash -- beginning of the period                3,545    8,366 
--------------------------------------------  ------   ------ 
Cash -- end of the period                      3,621    6,104 
--------------------------------------------  ------   ------ 
Cash is comprised of: 
   Cash                                        3,534    6,017 
   Restricted cash                                87       87 
--------------------------------------------  ------   ------ 
                                               3,621    6,104 
    ----------------------------------------  ------   ------ 
Cash paid for interest                            --       -- 
Cash paid for income tax                          --       -- 
--------------------------------------------  ------   ------

View source version on businesswire.com: https://www.businesswire.com/news/home/20241210683224/en/ 

 
    CONTACT:

Investor Relations Contact

investors@ipatherapeutics.com

(END) Dow Jones Newswires

December 10, 2024 08:30 ET (13:30 GMT)

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment